Symrise AG

Symrise AG is a German-based specialist in providing a comprehensive array of ingredients, encompassing fragrances, flavor compounds, active cosmetic components, and functional raw materials. Its operations are structured into two principal divisions: Taste, Nutrition & Health, and Scent & Care. The 'Taste, Nutrition & Health' division focuses on delivering flavor solutions and functional ingredients for the food and beverage industry, along with savory flavorings. It supplies natural and sustainable ingredients for diverse applications such as baby food and dietary supplements. This segment also extends its offerings to specialized product solutions and services for pet food and aqua feed manufacturers, in addition to providing probiotics for use in food supplements and functional foods. Conversely, the 'Scent & Care' segment is dedicated to the development, production, and sale of fragrance components, aroma molecules, cosmetic ingredients, and mint flavors, including their specific application technologies. Products from this segment are integral to a wide range of consumer goods, serving manufacturers of perfumes, personal care items, cosmetics, cleaning products, detergents, air fresheners, and oral hygiene products. Symrise AG maintains a broad international presence, conducting business across Europe, Africa, the Middle East, North America, Asia Pacific, and Latin America. The company was established in 1874 and has its headquarters in Holzminden, Germany.

Symrise AG trades as SY1.DE on XETRA. The company is classified in Basic Materials / Chemicals - Specialty and reports in EUR.

The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Symrise AG can be compared against peers such as Alcoa Corporation, Covestro AG, Covestro AG, Brenntag SE, Coeur Mining, Inc., Evonik Industries AG.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of €11.35B, beta of 0.57, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

SY1.DE currently shows total debt of N/A and beta of 0.57. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.symrise.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.